Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Rychnov Nad Kneznou – page 2

24 clinical trials in Rychnov Nad Kneznou, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Rychnov Nad Kneznou at a glance
24
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

24 trials in Rychnov Nad Kneznou

Open in trial search

Migraine+2

Not recruiting

Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Parkinson's disease

Not recruiting

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tavapadon
  • Sponsor:Cerevel Therapeutics LLC

Back pain

Not recruiting

Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH

Diabetic neuropathy

Not recruiting

Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cannabis Sativa Flower
  • Sponsor:Syqe Medical Ltd.

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Valiltramiprosate
  • Sponsor:Alzheon Inc.

Diabetic neuropathy

Not recruiting

Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LY3556050
  • Sponsor:Eli Lilly & Co.

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Mirodenafil Dihydrochloride
  • Sponsor:Aribio Co. Ltd.

Study of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ACP-204 tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pegipanermin
  • Sponsor:Inmune Bio Inc.

Migraine+2

Not recruiting

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Rychnov Nad Kneznou

What the registry says about research in the country

01 Neurodegenerative Disorders

Extensive research focusing on Alzheimer's Disease treatments, including studies of early-stage interventions and combination therapies. Multiple trials are investigating novel compounds for cognitive enhancement and symptom management.

  • Early Alzheimer's Disease with inflammation biomarkers
  • Mild to moderate Alzheimer's Disease
  • Alzheimer's Disease Psychosis

Additional investigations include Parkinson's Disease treatment evaluating long-term safety and effectiveness of new therapeutic approaches.

02 Neurological Pain Management

Innovative trials exploring treatments for various pain conditions, with particular emphasis on diabetic peripheral neuropathy and chronic pain management.

  • Diabetic Peripheral Neuropathic Pain
  • Chronic Non-specific Low Back Pain
  • Medical Cannabis Applications

Studies are evaluating both traditional pharmaceuticals and alternative therapeutic approaches for pain relief.

03 Migraine Research

Comprehensive studies investigating new treatments for migraine management, including both acute treatment and prevention strategies.

  • Episodic Migraine Treatment
  • Chronic Migraine Prevention
  • Long-term Migraine Management

Multiple therapeutic approaches are being tested to address both acute episodes and chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.